EICOSAPENTAENOIC ACID (EPA) IMPAIRS ABCA1-AND SR-BI-MEDIATED CHOLESTEROL EFFLUX FROM CHOLESTEROL-LOADED HUMAN THP-1 MACROPHAGES BY REDUCING THE CHOLESTERYL ESTER MOBILIZATION FROM LIPID DROPLETS

被引：0
|
作者：
Dakroub, H. [1 ]
Nowak, M. [1 ]
Rousseau-Ralliard, D. [2 ]
Paul, J. -L. [1 ]
Fournier, N. [1 ]
机构：
[1] Univ Paris Saclay, Ea 7357 Lipsys2 Unit, Biol Team, Fac Pharm, Orsay, France
[2] INRAE, Breed, Jouy En Josas, France
来源：
ATHEROSCLEROSIS | 2023年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SS075
引用
收藏
页数：1
相关论文
共 48 条
  • [31] Tribbles homolog 1 enhances cholesterol efflux from oxidized low-density lipoprotein-loaded THP-1 macrophages
    Fu, Yanhua
    Zhao, Yang
    Huang, Bin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 862 - 866
  • [32] Eicosapentaenoic acid membrane incorporation impairs ABCA1-dependent cholesterol efflux via a protein kinase A signaling pathway in primary human macrophages
    Fournier, Natalie
    Tardivel, Sylviane
    Benoist, Jean-Francois
    Vedie, Benoit
    Rousseau-Ralliard, Delphine
    Nowak, Maxime
    Allaoui, Fatima
    Paul, Jean-Louis
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (04): : 331 - 341
  • [33] Consumption of vegetable oils with different unsaturated fatty acid profiles increases cholesterol efflux from THP-1 macrophages
    Liu, Xiaoran
    Kris-Etherton, Penny
    West, Sheila
    Lamarche, Benoit
    Couture, Patrick
    Jenkins, David
    Fleming, Jennifer
    Vanden Heuvel, Jack
    Jones, Peter
    FASEB JOURNAL, 2014, 28 (01):
  • [34] RESVERATROL EXHIBITS ANTI-ATHEROGENIC PROPERTIES BY FACILITATING CHOLESTEROL EFFLUX FROM THP-1 HUMAN MONOCYTES/MACROPHAGES
    Hai, O.
    Anwar, K.
    Wirkowski, P. A.
    Voloshyna, I.
    Carsons, S.
    Reiss, A. B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (03) : 590 - 590
  • [35] TRANS ELAIDIC BUT NOT VACCENIC ACID IMPAIRS ABCA1-DEPENDENT CHOLESTEROL EFFLUX FROM J774 MACROPHAGES
    Fournier, N.
    Attia, N.
    Rousseau, D.
    Vedie, B.
    Destaillats, F.
    Grynberg, A.
    Paul, J. -L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 81 - 81
  • [36] ADIPOCYTE-DERIVED EXOSOMES FROM OBESE SUBJECTS HAVE ATHEROGENIC EFFECTS ON CHOLESTEROL EFFLUX IN THP-1 HUMAN MACROPHAGES
    Siegart, Nicolle M.
    Reiss, Allison B.
    De Leon, Joshua
    Voloshyna, Iryna
    Barlev, Ashley
    Salama, Michael
    Ferrante, Sarah
    Nadler, Evan
    Freishtat, Robert J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (03) : 730 - 730
  • [37] Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART
    El Khoury, Petra
    Ghislain, Mathilde
    Villard, Elise F.
    Le Goff, Wilfried
    Lascoux-Combe, Caroline
    Yeni, Patrick
    Meyer, Laurence
    Vigouroux, Corinne
    Goujard, Cecile
    Guerin, Maryse
    JOURNAL OF LIPID RESEARCH, 2015, 56 (03) : 692 - 702
  • [38] Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling
    Yang, Hui-Yu
    Bian, Yun-Fei
    Xiao, Chuan-Shi
    Liang, Bin
    Zhang, Nana
    Gao, Fen
    Yang, Zhi-Ming
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 1387 - 1392
  • [39] MBX-2599, a novel PPAR d/g dual agonist regulates genes involved in reverse cholesterol transport and stimulates apolipoprotein-mediated cholesterol efflux from human THP-1 macrophages
    Rakhmanova, V
    Zhang, F
    Zhu, Y
    Ma, JY
    Cheng, P
    Zhao, S
    Lavan, B
    Gustafson, TA
    Gregoire, FM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E57 - E57
  • [40] INHIBITION OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RESTORES CHOLESTEROL EFFLUX IN THP-1 HUMAN MACROPHAGES EXPOSED TO PLASMA FROM TYPE 1 DIABETES MELLITUS PATIENTS
    Corletto, J. M.
    Accacha, S.
    Voloshyna, I.
    Siegart, N.
    Kasselman, L.
    Magana, M. C.
    DeLeon, J.
    Reiss, A. B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (03) : 800 - 800
12345